{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T03:10:41Z","timestamp":1778728241774,"version":"3.51.4"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000156","name":"Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thrombosisresearch.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Thrombosis Research"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.thromres.2026.109691","type":"journal-article","created":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T06:50:57Z","timestamp":1776840657000},"page":"109691","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Clinical outcomes following catheter-related venous thrombo-embolism among children with acute lymphoblastic leukemia"],"prefix":"10.1016","volume":"261","author":[{"given":"Marie-Claude","family":"Pelland-Marcotte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thai Hoa","family":"Tran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chantal","family":"\u00c9thier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camille","family":"Beaulieu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thien Vu","family":"Truong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia","family":"Tarhini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliann","family":"Duzan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lynda M.","family":"Vrooman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa","family":"Burns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lewis B.","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riten","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.thromres.2026.109691_bb0005","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1586\/17474086.2013.842124","article-title":"Thrombosis in pediatric cancer: identifying the risk factors to improve care","volume":"6","author":"Athale","year":"2013","journal-title":"Expert Rev. Hematol."},{"issue":"3","key":"10.1016\/j.thromres.2026.109691_bb0010","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1200\/JCO.2005.03.8877","article-title":"Thromboembolism in hospitalized neutropenic cancer patients","volume":"24","author":"Khorana","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"3","key":"10.1016\/j.thromres.2026.109691_bb0015","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.thromres.2011.10.025","article-title":"Anticancer treatment and thrombosis","volume":"129","author":"Falanga","year":"2012","journal-title":"Thromb. Res."},{"issue":"9","key":"10.1016\/j.thromres.2026.109691_bb0020","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1055\/s-0038-1668543","article-title":"Thromboembolism incidence and risk factors in children with cancer: a population-based cohort study","volume":"118","author":"Pelland-Marcotte","year":"2018","journal-title":"Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.thromres.2026.109691_bb0025","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1160\/TH13-10-0827","article-title":"Epidemiology of venous thrombosis in children with cancer","volume":"111","author":"Piovesan","year":"2014","journal-title":"Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.thromres.2026.109691_bb0030","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1365-2141.2005.05528.x","article-title":"Thromboembolism in children with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute protocols: effect of age and risk stratification of disease","volume":"129","author":"Athale","year":"2005","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.thromres.2026.109691_bb0035","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.thromres.2016.05.015","article-title":"Age at cancer diagnosis, non-O blood group and asparaginase therapy are independently associated with deep venous thrombosis in pediatric oncology patients: a risk model","volume":"144","author":"Spavor","year":"2016","journal-title":"Thromb. Res."},{"issue":"7","key":"10.1016\/j.thromres.2026.109691_bb0040","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1182\/blood-2006-04-015511","article-title":"Thrombotic complications in childhood acute lymphoblastic leukemia: a meta-analysis of 17 prospective studies comprising 1752 pediatric patients","volume":"108","author":"Caruso","year":"2006","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.thromres.2026.109691_bb0045","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1182\/blood.V83.5.1251.1251","article-title":"Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE","volume":"83","author":"Andrew","year":"1994","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.thromres.2026.109691_bb0050","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1182\/blood.2019002260","article-title":"Peripherally inserted central catheters lead to a high risk of venous thromboembolism in children","volume":"135","author":"Jaffray","year":"2020","journal-title":"Blood"},{"issue":"28","key":"10.1016\/j.thromres.2026.109691_bb0055","doi-asserted-by":"crossref","first-page":"4575","DOI":"10.1200\/JCO.2005.05.5343","article-title":"Catheter-related deep venous thrombosis and other catheter complications in children with cancer","volume":"24","author":"Journeycake","year":"2006","journal-title":"J. Clin. Oncol."},{"issue":"22","key":"10.1016\/j.thromres.2026.109691_bb0060","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1182\/blood-2018-01-827949","article-title":"Thromboembolism in acute lymphoblastic leukemia: results of NOPHO ALL2008 protocol treatment in patients aged 1 to 45 years","volume":"131","author":"Rank","year":"2018","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.thromres.2026.109691_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2025.102986","article-title":"Long-term impact of central venous catheters in pediatric cancer survivors","volume":"9","author":"Cusson","year":"2025","journal-title":"Res. Pract. Thromb. Haemost."},{"issue":"10","key":"10.1016\/j.thromres.2026.109691_bb0070","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1182\/bloodadvances.2024015328","article-title":"American Society of Hematology\/International Society on Thrombosis and Haemostasis 2024 updated guidelines for treatment of venous thromboembolism in pediatric patients","volume":"9","author":"Monagle","year":"2025","journal-title":"Blood Adv."},{"key":"10.1016\/j.thromres.2026.109691_bb0075","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.828702","article-title":"Thrombosis complications in pediatric acute lymphoblastic leukemia: risk factors, management, and prevention: is there any role for pharmacologic prophylaxis?","volume":"10","author":"Rodriguez","year":"2022","journal-title":"Front. Pediatr."},{"issue":"12","key":"10.1016\/j.thromres.2026.109691_bb0080","first-page":"2913","article-title":"Recognition, prevention, and management of adverse events associated with asparaginase\/ pegaspargase treatment of acute lymphoblastic leukemia in adults: consensus of an expert panel","volume":"110","author":"Curran","year":"2025","journal-title":"Haematologica"},{"key":"10.1016\/j.thromres.2026.109691_bb0085","series-title":"SickKids handbook of Thrombosis and Haemostasis","article-title":"Venous thrombosis","author":"Pelland-Marcotte","year":"2023"},{"issue":"3","key":"10.1016\/j.thromres.2026.109691_bb0090","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1182\/blood.2021013453","article-title":"Prevention of recurrent thrombotic events in children with central venous catheter-associated venous thrombosis","volume":"139","author":"Clark","year":"2022","journal-title":"Blood"},{"issue":"24","key":"10.1016\/j.thromres.2026.109691_bb0095","doi-asserted-by":"crossref","first-page":"2712","DOI":"10.1182\/blood-2017-10-811216","article-title":"Can thrombophilia predict recurrent catheter-related deep vein thrombosis in children?","volume":"131","author":"Avila","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.thromres.2026.109691_bb0100","series-title":"Common Terminology Criteria for Adverse Events (CTCAE) v4.0","author":"Cancer Therapy Evaluation Program","year":"2009"},{"issue":"16","key":"10.1016\/j.thromres.2026.109691_bb0105","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S1470-2045(15)00363-0","article-title":"Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial","volume":"16","author":"Place","year":"2015","journal-title":"Lancet Oncol."},{"issue":"31","key":"10.1016\/j.thromres.2026.109691_bb0110","doi-asserted-by":"crossref","first-page":"3496","DOI":"10.1200\/JCO.20.03692","article-title":"Efficacy and toxicity of pegaspargase and calaspargase pegol in childhood acute lymphoblastic leukemia: results of DFCI 11-001","volume":"39","author":"Vrooman","year":"2021","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.thromres.2026.109691_bb0115","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1182\/bloodadvances.2021005634","article-title":"Whole-transcriptome analysis in acute lymphoblastic leukemia: a report from the DFCI ALL Consortium Protocol 16-001","volume":"6","author":"Tran","year":"2022","journal-title":"Blood Adv."},{"issue":"22","key":"10.1016\/j.thromres.2026.109691_bb0120","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1182\/bloodadvances.2018024786","article-title":"American Society of Hematology 2018 Guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism","volume":"2","author":"Monagle","year":"2018","journal-title":"Blood Adv."},{"issue":"8","key":"10.1016\/j.thromres.2026.109691_bb0125","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1182\/blood.V99.8.2734","article-title":"Comparison of Escherichia coli-asparaginase with Erwinia-asparaginase in the treatment of childhood lymphoid malignancies: results of a randomized European Organisation for Research and Treatment of Cancer-Children\u2019s Leukemia Group phase 3 trial","volume":"99","author":"Duval","year":"2002","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.thromres.2026.109691_bb0130","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/S1470-2045(17)30424-2","article-title":"Asparaginase-associated pancreatitis in childhood acute lymphoblastic leukaemia: an observational Ponte di Legno Toxicity Working Group study","volume":"18","author":"Wolthers","year":"2017","journal-title":"Lancet Oncol."},{"issue":"9","key":"10.1016\/j.thromres.2026.109691_bb0135","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1111\/j.1538-7836.2011.04433.x","article-title":"Definition of clinical efficacy and safety outcomes for clinical trials in deep venous thrombosis and pulmonary embolism in children","volume":"9","author":"Mitchell","year":"2011","journal-title":"J. Thromb. Haemost."},{"issue":"6","key":"10.1016\/j.thromres.2026.109691_bb0140","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1016\/j.jtha.2023.03.004","article-title":"Updated guidance for efficacy and safety outcomes for clinical trials in venous thromboembolism in children: communication from the ISTH SSC Subcommittee on Pediatric and Neonatal Thrombosis and Hemostasis","volume":"21","author":"Whitworth","year":"2023","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.thromres.2026.109691_bb0145","series-title":"Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis","volume":"vol. 608","author":"Harrell","year":"2001"},{"issue":"7","key":"10.1016\/j.thromres.2026.109691_bb0150","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1002\/sim.7992","article-title":"Minimum sample size for developing a multivariable prediction model: PART II-binary and time-to-event outcomes","volume":"38","author":"Riley","year":"2019","journal-title":"Stat. Med."},{"issue":"7","key":"10.1016\/j.thromres.2026.109691_bb0155","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1182\/blood.2019000998","article-title":"Safety of dabigatran etexilate for the secondary prevention of venous thromboembolism in children","volume":"135","author":"Brandao","year":"2020","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.thromres.2026.109691_bb0160","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.3324\/haematol.2010.026989","article-title":"Post-thrombotic syndrome in children: a systematic review of frequency of occurrence, validity of outcome measures, and prognostic factors","volume":"95","author":"Goldenberg","year":"2010","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.thromres.2026.109691_bb0165","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1016\/S2352-3026(20)30368-9","article-title":"Dabigatran etexilate for the treatment of acute venous thromboembolism in children (DIVERSITY): a randomised, controlled, open-label, phase 2b\/3, non-inferiority trial","volume":"8","author":"Halton","year":"2021","journal-title":"Lancet Haematol."},{"issue":"1","key":"10.1016\/j.thromres.2026.109691_bb0170","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1016\/S2352-3026(19)30219-4","article-title":"Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial","volume":"7","author":"Male","year":"2020","journal-title":"Lancet Haematol."},{"issue":"3","key":"10.1016\/j.thromres.2026.109691_bb0175","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1055\/s-0044-1790572","article-title":"Secondary anticoagulation use in patients<21 years old following primary anticoagulant treatment for provoked venous thromboembolism: findings from the Kids-DOTT trial","volume":"51","author":"Wilson","year":"2025","journal-title":"Semin. Thromb. Hemost."},{"issue":"6","key":"10.1016\/j.thromres.2026.109691_bb0180","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1111\/jth.15699","article-title":"Venous thromboembolism in pediatric patients with acute lymphoblastic leukemia under chemotherapy treatment. Risk factors and usefulness of thromboprophylaxis. Results of LAL-SEHOP-PETHEMA-2013","volume":"20","author":"Ruiz-Llobet","year":"2022","journal-title":"J. Thromb. Haemost."},{"issue":"4","key":"10.1016\/j.thromres.2026.109691_bb0185","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1365-2141.2010.08524.x","article-title":"The frequency and management of asparaginase-related thrombosis in paediatric and adult patients with acute lymphoblastic leukaemia treated on Dana-Farber Cancer Institute consortium protocols","volume":"152","author":"Grace","year":"2011","journal-title":"Br. J. Haematol."},{"issue":"1","key":"10.1016\/j.thromres.2026.109691_bb0190","doi-asserted-by":"crossref","first-page":"e27","DOI":"10.1016\/S2352-3026(23)00314-9","article-title":"Apixaban versus no anticoagulation for the prevention of venous thromboembolism in children with newly diagnosed acute lymphoblastic leukaemia or lymphoma (PREVAPIX-ALL): a phase 3, open-label, randomised, controlled trial","volume":"11","author":"O\u2019Brien","year":"2024","journal-title":"Lancet Haematol."},{"issue":"4","key":"10.1016\/j.thromres.2026.109691_bb0195","doi-asserted-by":"crossref","first-page":"756","DOI":"10.3324\/haematol.2018.194175","article-title":"THROMBOTECT - a randomized study comparing low molecular weight heparin, antithrombin and unfractionated heparin for thromboprophylaxis during induction therapy of acute lymphoblastic leukemia in children and adolescents","volume":"104","author":"Greiner","year":"2019","journal-title":"Haematologica"},{"key":"10.1016\/j.thromres.2026.109691_bb0200","article-title":"Safety and efficacy of apixaban thrombosis prevention in the obese pediatric patients with acute lymphoblastic leukemia","author":"Rodriguez","year":"2025","journal-title":"Blood Adv."},{"issue":"2","key":"10.1016\/j.thromres.2026.109691_bb0205","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.35673","article-title":"Impact of obesity on outcome in children diagnosed with cancer in Canada: a report from cancer in young people in Canada","volume":"131","author":"Sassine","year":"2025","journal-title":"Cancer"},{"issue":"4","key":"10.1016\/j.thromres.2026.109691_bb0210","doi-asserted-by":"crossref","DOI":"10.1097\/CCM.0000000000004848","article-title":"Age-dependent heterogeneity in the efficacy of prophylaxis with enoxaparin against catheter-associated thrombosis in critically ill children: a post hoc analysis of a Bayesian phase 2b randomized clinical trial","volume":"49","author":"Faustino","year":"2021","journal-title":"Crit. Care Med."},{"issue":"4","key":"10.1016\/j.thromres.2026.109691_bb0215","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/jth.15260","article-title":"International pediatric thrombosis network to advance pediatric thrombosis research: communication from the ISTH SSC subcommittee on pediatric and neonatal thrombosis and hemostasis","volume":"19","author":"van Ommen","year":"2021","journal-title":"J. Thromb. Haemost."}],"container-title":["Thrombosis Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384826001106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049384826001106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T02:42:32Z","timestamp":1778726552000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049384826001106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":43,"alternative-id":["S0049384826001106"],"URL":"https:\/\/doi.org\/10.1016\/j.thromres.2026.109691","relation":{},"ISSN":["0049-3848"],"issn-type":[{"value":"0049-3848","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical outcomes following catheter-related venous thrombo-embolism among children with acute lymphoblastic leukemia","name":"articletitle","label":"Article Title"},{"value":"Thrombosis Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.thromres.2026.109691","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"109691"}}